Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead (Q33891197)

29 July 2017

1 reference

title

Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead (English)

1 reference

29 July 2017

0 references

Sandipan Ray

1

1 reference

29 July 2017

Panga J Reddy

2

1 reference

29 July 2017

Rekha Jain

3

1 reference

29 July 2017

Kishore Gollapalli

4

1 reference

29 July 2017

Aliasgar Moiyadi

5

1 reference

29 July 2017

Sanjeeva Srivastava

6

1 reference

29 July 2017

4 May 2011

1 reference

29 July 2017

1 reference

29 July 2017

11

1 reference

29 July 2017

2139-2161

1 reference

29 July 2017

11

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

29 July 2017

1 reference

The use of proteomics to identify novel therapeutic targets for the treatment of disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Applications of current proteomics techniques in modern drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Serum proteomics in cancer diagnosis and management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

The blood peptidome: a higher dimension of information content for cancer biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Clinical proteomics: translating benchside promise into bedside reality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Recent advances in blood-related proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Human body fluid proteome analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Determining tumor apoptosis and necrosis in patient serum using cytokeratin 18 as a biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Cytokeratin markers come of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Clinical proteomics: Written in blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

The human plasma proteome: history, character, and diagnostic prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Serum and plasma proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Advances, challenges, and limitations in serum-proteome-based cancer diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Proteomics techniques and their application to hematology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Glycoproteomics for prostate cancer detection: changes in serum PSA glycosylation patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Profiling protein markers associated with lymph node metastasis in prostate cancer by DIGE-based proteomics analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Identification of S100A8 and S100A9 as serological markers for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Searching for serum tumor markers for colorectal cancer using a 2-D DIGE approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Discovery of serum biomarkers in astrocytoma by SELDI-TOF MS and proteinchip technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Serum alpha 2-HS glycoprotein predicts survival in patients with glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Application of protein microarrays for multiplexed detection of antibodies to tumor antigens in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Mass spectrometry (LC-MS/MS) site-mapping of N-glycosylated membrane proteins for breast cancer biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

The multiplex bead array approach to identifying serum biomarkers associated with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Combination of improved (18)O incorporation and multiple reaction monitoring: a universal strategy for absolute quantitative verification of serum candidate biomarkers of liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Proteomics of hepatocellular carcinoma: serum vimentin as a surrogate marker for small tumors (<or=2 cm).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Differential proteomics identification of HSP90 as potential serum biomarker in hepatocellular carcinoma by two-dimensional electrophoresis and mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Serum proteomic-based analysis of pancreatic carcinoma for the identification of potential cancer biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

The identification of phosphoglycerate kinase-1 and histone H4 autoantibodies in pancreatic cancer patient serum using a natural protein microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Use of a single-chain antibody library for ovarian cancer biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

p53 autoantibodies as potential detection and prognostic biomarkers in serous ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Proteomic analysis of serum in lung cancer induced by 3-methylcholanthrene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Serum S100A6 concentration predicts peritoneal tumor burden in mice with epithelial ovarian cancer and is associated with advanced stage in patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Quantification of C-reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C-labeled peptide standards

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Proteomic analysis of secreted proteins in early rheumatoid arthritis: anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Protein expression profiles in pediatric multiple sclerosis: potential biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Serum levels of complement C4 fragments correlate with disease activity in multiple sclerosis: proteomic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Biomarker discovery for inflammatory bowel disease, using proteomic serum profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Identification of novel serological biomarkers for inflammatory bowel disease using Escherichia coli proteome chip

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Plasma proteome of severe acute respiratory syndrome analyzed by two-dimensional gel electrophoresis and mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

The use of proteomics in the discovery of serum biomarkers from patients with severe acute respiratory syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Serum biomarkers of hepatitis B virus infected liver inflammation: A proteomic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Serum proteomic analysis focused on fibrosis in patients with hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Serum proteome of leprosy patients undergoing erythema nodosum leprosum reaction: regulation of expression of the isoforms of haptoglobin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Fatty acid binding protein as a serum marker for the early diagnosis of stroke: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

ApoC-I and ApoC-III as potential plasmatic markers to distinguish between ischemic and hemorrhagic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Proteomic analysis of maternal serum in down syndrome: identification of novel protein biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Quantitative proteomics analysis of maternal plasma in Down syndrome pregnancies using isobaric tagging reagent (iTRAQ)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Potential biomarkers for diagnosis of sarcoidosis using proteomics in serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Systematical evaluation of the effects of sample collection procedures on low-molecular-weight serum/plasma proteome profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Correcting common errors in identifying cancer-specific serum peptide signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Sample handling for mass spectrometric proteomic investigations of human sera.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Potential interferences from blood collection tubes in mass spectrometric analyses of serum polypeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

The stability of the circulating human proteome to variations in sample collection and handling procedures measured with an aptamer-based proteomics array

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Progressive degradation of serum samples limits proteomic biomarker discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Serum proteome analysis for profiling protein markers associated with carcinogenesis and lymph node metastasis in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Artifactual isoform profile modification following treatment of human plasma or serum with protease inhibitor, monitored by 2-dimensional electrophoresis and mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Current two-dimensional electrophoresis technology for proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Two-dimensional difference gel electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

MALDI-TOF MS detection of dilute, volume-limited peptide samples with physiological salt levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Advancement of biomarker discovery and validation through the HUPO plasma proteome project

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

The temporal profile of the anti-PF4/heparin immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Serum vasopressin concentrations during orthotopic liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Quantitative mass spectrometry-based techniques for clinical use: biomarker identification and quantification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Mass spectrometry-based proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Global and targeted quantitative proteomics for biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

High throughput quantitative analysis of serum proteins using glycopeptide capture and liquid chromatography mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Tools for glycoproteomic analysis: size exclusion chromatography facilitates identification of tryptic glycopeptides with N-linked glycosylation sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Combination of affinity depletion of abundant proteins and reversed-phase fractionation in proteomic analysis of human plasma/serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Nanoparticle technology: Addressing the fundamental roadblocks to protein biomarker discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Mass spectrometry-based protein biomarker discovery: solving the remaining challenges to reach the promise of clinical benefit

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Concentration and Preservation of Very Low Abundance Biomarkers in Urine, such as Human Growth Hormone (hGH), by Cibacron Blue F3G-A Loaded Hydrogel Particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Core-shell hydrogel particles harvest, concentrate and preserve labile low abundance biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Selective binding and enrichment for low-molecular weight biomarker molecules in human plasma after exposure to nanoporous silica particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Investigation of the ovarian and prostate cancer peptidome for candidate early detection markers using a novel nanoparticle biomarker capture technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Serum proteomics of glioma: methods and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Biomarkers: mining the biofluid proteome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

An investigation into the human serum "interactome"

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Difference gel electrophoresis: a single gel method for detecting changes in protein extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Protein stains for proteomic applications: which, when, why?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Automated serum peptide profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Biomarker discovery from the plasma proteome using multidimensional fractionation proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Quantitative analysis of complex protein mixtures using isotope-coded affinity tags

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Properties of 13C-Substituted Arginine in Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Search for cancer markers from endometrial tissues using differentially labeled tags iTRAQ and cICAT with multidimensional liquid chromatography and tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Assessing the effects of diurnal variation on the composition of human parotid saliva: quantitative analysis of native peptides using iTRAQ reagents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Robust and sensitive iTRAQ quantification on an LTQ Orbitrap mass spectrometer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

8-plex quantitation of changes in cerebrospinal fluid protein expression in subjects undergoing intravenous immunoglobulin treatment for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Chip-LC-MS for label-free profiling of human serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Multidimensional protein fractionation of blood proteins coupled to data-independent nanoLC-MS/MS analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

A comparison of labeling and label-free mass spectrometry-based proteomics approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Comparison of label-free methods for quantifying human proteins by shotgun proteomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Analysis of polyamines as carbamoyl derivatives in urine and serum by liquid chromatography-tandem mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

High-throughput ultra-high-performance liquid chromatography/tandem mass spectrometry quantitation of insulin-like growth factor-I and leucine-rich alpha-2-glycoprotein in serum as biomarkers of recombinant human growth hormone administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Multiple reaction monitoring for quantitative biomarker analysis in proteomics and metabolomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

The bottleneck in the cancer biomarker pipeline and protein quantification through mass spectrometry-based approaches: current strategies for candidate verification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Clinical quantitation of prostate-specific antigen biomarker in the low nanogram/milliliter range by conventional bore liquid chromatography-tandem mass spectrometry (multiple reaction monitoring) coupling and correlation with ELISA tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Differential secreted proteome approach in murine model for candidate biomarker discovery in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

High-throughput proteomics using antibody microarrays: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Applications of protein microarrays for biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Reverse-phase versus sandwich antibody microarray, technical comparison from a clinical perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Reverse phase protein microarrays advance to use in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Development of reverse phase protein microarrays for the validation of clusterin, a mid-abundant blood biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Reverse-phase protein microarrays: application to biomarker discovery and translational medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Validation of reverse phase protein array for practical screening of potential biomarkers in serum and plasma: accurate detection of CA19-9 levels in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Antibody arrays in cancer research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Design of recombinant antibody microarrays for serum protein profiling: targeting of complement proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Design of recombinant antibody microarrays for complex proteome analysis: choice of sample labeling-tag and solid support

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Antibody microarray analysis of directly labelled complex proteomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Serum proteome profiling of metastatic breast cancer using recombinant antibody microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Design of high-density antibody microarrays for disease proteomics: key technological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Plasma proteome profiling reveals biomarker patterns associated with prognosis and therapy selection in glioblastoma multiforme patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Comparative protein profiling of serum and plasma using an antibody suspension bead array approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Cell-free synthesis-based protein microarrays and their applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Profiling humoral immune responses to P. falciparum infection with protein microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Label-free detection techniques for protein microarrays: prospects, merits and challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Label-free detection of cancer biomarker candidates using surface plasmon resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Label-free immunosensing for alpha-fetoprotein in human plasma using surface plasmon resonance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

ssDNA aptamer-based surface plasmon resonance biosensor for the detection of retinol binding protein 4 for the early diagnosis of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Multiplexed electrical detection of cancer markers with nanowire sensor arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Label-free immunosensor for prostate-specific antigen based on single-walled carbon nanotube array-modified microelectrodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Label-free quantitation of a cancer biomarker in complex media using silicon photonic microring resonators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Label-free biomarker sensing in undiluted serum with suspended microchannel resonators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

On-chip enzyme immunoassay of a cardiac marker using a microfluidic device combined with a portable surface plasmon resonance system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Cancer nanotechnology: opportunities and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Proteomics, nanotechnology and molecular diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Nanotechniques in proteomics: current status, promises and challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Disposable electrochemical immunosensor for carcinoembryonic antigen using ferrocene liposomes and MWCNT screen-printed electrode.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Label-free electrical detection of cardiac biomarker with complementary metal-oxide semiconductor-compatible silicon nanowire sensor arrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Single-wall carbon nanotube forest arrays for immunoelectrochemical measurement of four protein biomarkers for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Peptide-coated nanotube-based biosensor for the detection of disease-specific autoantibodies in human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

A reagentless amperometric immunosensor for alpha-1-fetoprotein based on gold nanowires and ZnO nanorods modified electrode.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Protein microarrays with carbon nanotubes as multicolor Raman labels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Electrical detection of VEGFs for cancer diagnoses using anti-vascular endotherial growth factor aptamer-modified Si nanowire FETs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Detection of human proteins using arrayed imaging reflectometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Real-time label-free detection of complement activation products in human serum by white light reflectance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Label-free, all-electrical, in situ human epidermal growth receptor 2 detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Sensitivity enhancement of a dynamic mode microcantilever by stress inducer and mass inducer to detect PSA at low picogram levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

7(th) HUPO World Congress of Proteomics: launching the second phase of the HUPOPlasma Proteome Project (PPP-2) 16-20 August 2008, Amsterdam, The Netherlands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Data management and data integration in the HUPO plasma proteome project

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

A novel, high-throughput workflow for discovery and identification of serum carrier protein-bound peptide biomarker candidates in ovarian cancer samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

IPO-38 is identified as a novel serum biomarker of gastric cancer based on clinical proteomics technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Bioassay of prostate-specific antigen (PSA) using microcantilevers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Head-to-Head Comparison of Serum Fractionation Techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

A label-free nano-liquid chromatography-mass spectrometry approach for quantitative serum peptidomics in Crohn's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

Antibody Suspension Bead Arrays within Serum Proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201000460

21 January 2018

Identifiers

DOI

10.1002/PMIC.201000460

1 reference

29 July 2017

1 reference